<DOC>
	<DOCNO>NCT00180375</DOCNO>
	<brief_summary>This study evaluate date first appropriate and/or inappropriate therapy patient implant Guidant PRIZM VITALITY defibrillator evaluate eventual predictive risk factor appropriate/inappropriate therapy well influence programmed parameter therapy .</brief_summary>
	<brief_title>OPERA : French Observational Study Patients Implanted With Guidant PRIZM Vitality Defibrillator</brief_title>
	<detailed_description>The registry measure time , study determinant , first appropriate ( FAT ) inappropriate ( FIT ) therapy deliver single , dual triple chamber ( CRT-D ) ICD implant primary secondary prevention indication .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>Indication ICD accord current guideline , incl . prophylactic indication pregnant birth bearing age without contraception , participation another clinical trial , short life expectancy , geographically unstable followup investigational center</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>